X

Pot Stocks Post-Roll – Aurora (ACB), Valens (VLNS) & MediPharm (LABS)

Scott Willis and Thomas George talk cannabis stocks on the Post-Roll, this week we’re taking questions from the mail bag!

Subscribe Now
Sign up to get Grizzle's latest news and analysis in your inbox!

Sending Message...


We evaluate the likelihood of a short squeeze on Aurora (TSE: ACB, NYSE: ACB) given the massive short interest in the company. Colorado rebounding flower pricing potentially providing a silver lining for pot stocks. Which cannabis oil stock to own: Valens (TSXV: VLNS) vs. MediPharm (TSE: LABS)? We also put odds on the next CEO to get dropped kicked from the cannabis C-suite!

The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Grizzle hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.

Subscribe Now
Sign up to get Grizzle's latest news and analysis in your inbox!

Sending Message...


Categories: Marijuana Analysis
Editor: Grizzle identifies the opportunities and risks for the new money paradigm.
Related Post
Disqus Comments Loading...